-+ 0.00%
-+ 0.00%
-+ 0.00%

Regentis Biomaterials Strikes Distribution Deal With AMI Medical Technologies To Commercialize GelrinC In Israel

Benzinga·11/09/2026 14:01:58
Listen to the news

Regentis Biomaterials Ltd. ("Regentis" or the "Company") (NYSE American:RGNT), a regenerative medicine company focused on innovative tissue repair solutions, today announced that it has entered into a four-year exclusive distribution agreement with AMI Medical Technologies Ltd. ("AMI"), a leading Israeli medical technology distributor, for the commercialization of GelrinC®, Regentis' proprietary implant for the repair of damaged knee cartilage, in Israel.